Phase I study of ALKS-7106 in volunteers
Phase of Trial: Phase I
Latest Information Update: 24 Feb 2015
Price : $35 *
At a glance
- Drugs ALKS 7106 (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacokinetics
- 24 Feb 2015 Status changed from recruiting to completed, as reported in an Alkermes media release.
- 26 Aug 2014 Status changed from planning to recruiting, according to an Alkermes media release.
- 26 Aug 2014 This trial has been initiated and results are expected in the first half of 2015, according to an Alkermes media release.